13 January 2022PatentsMuireann Bolger

2022 forecast: AI, Fintiv rule, Arthrex

In the third part of WIPR’s forecast series, leading lawyers offer their views on, what lies ahead for artificial intelligence in the IP landscape, and the beleaguered Patent Trial and Appeal Board’s (PTAB) likely future stance on the NHK-Fintiv rule and Arthrex-related requests for inter partes reviews of patents.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

USPTO seeks opinions on Arthrex director reviews

25 April 2022 The US Patent and Trademark Office is seeking input to help formalise the process that allows the director to review decisions handed down by the Patent Trial and Appeal Board.

Patents

SCOTUS dismisses Intel challenge to Fintiv rule

22 March 2022 The US Supreme Court has rejected an attempt by Intel to challenge the controversial NHK- Fintiv rule, the latest in a series of denials meted out to tech companies and generic drug makers seeking the same review.

Patents

Fintiv targets PayPal in mobile payment patent suit

18 March 2022 Tech company Fintiv has accused PayPal of using its patented mobile wallet technology without its permission.